Opposing effects of acellular and whole cell pertussis vaccines on biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues

Jesse M. Hall,Jessica L. Gutiérrez-Ferman,Mohamed M. Shamseldin,Myra Guo,Yash A. Gupta,Rajendar Deora,Purnima Dubey

DOI: https://doi.org/10.1101/2024.01.23.576795

2024-01-25

Abstract:Despite global vaccination, pertussis caused by ( ) is resurging. Pertussis resurgence is correlated with the switch from whole cell vaccines (wPV) that elicit T 1/T 17 polarized immune responses to acellular pertussis vaccines (aPV) that elicit primarily T 2 polarized immune responses. One explanation for the increased incidence in aPV-immunized individuals is the lack of bacterial clearance from the nose. To understand the host and bacterial mechanisms that contribute to persistence, we evaluated bacterial localization and the immune response in the nasal associated tissues (NT) of naïve and immunized mice following challenge. resided in the NT of unimmunized and aPV-immunized mice as biofilms. In contrast, biofilms were not observed in wPV-immunized mice. Following infection, Siglec-F+ neutrophils, critical for eliminating from the nose, were recruited to the nose at higher levels in wPV immunized mice compared to aPV immunized mice. Consistent with this observation, the neutrophil chemokine CXCL1 was only detected in the NT of wPV immunized mice. Importantly, the bacteria and immune cells were primarily localized within the NT and were not recovered by nasal lavage (NL). Together, our data suggest that the T 2 polarized immune response generated by aPV vaccination facilitates persistence in the NT by impeding the infiltration of immune effectors and the eradication of biofilms In contrast, the T 1/T 17 immune phenotype generated by wPV, recruits Siglec-F+ neutrophils that rapidly eliminate the bacterial burden and prevent biofilm establishment. Thus, our work shows that aPV and wPV have opposing effects on biofilm formation in the respiratory tract and provides a mechanistic explanation for the inability of aPV vaccination to control bacterial numbers in the nose and prevent transmission.

Immunology